Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in golden retriever muscular dystrophy dogs and duchenne muscular dystrophy patients

American Journal of Pathology

Volumn 184, Issue 11, 2014, Pages 2885-2898

  Jeanson Leh, Laurence ^a   Lameth, Julie ^a   Krimi, Soraya ^a   Buisset, Julien ^a   Amor, Fatima ^a   Le Guiner, Caroline ^a,b   Barthélémy, Inès ^c   Servais, Laurent ^d   Blot, Stéphane ^c   Voit, Thomas ^e,f   Israeli, David ^a  

^a GÉNÉTHON   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^d Institut de Myologie   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f Sorbonne Université   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 206; MICRORNA 208A; MICRORNA 208B; MICRORNA 378; MICRORNA 499; MICRORNA 95; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANINE MODEL; CARDIOMYOPATHY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUCHENNE MUSCULAR DYSTROPHY; GENE CONTROL; GENE IDENTIFICATION; GOLDEN RETRIEVER; HEART DISEASE; HUMAN; MALE; MOUSE; MUSCLE LEVEL; MUSCULAR DYSTROPHY; NONHUMAN; ANIMAL; CHILD; DISEASE MODEL; DOG; GENETICS; METABOLISM; PRESCHOOL CHILD; SKELETAL MUSCLE;

ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MALE; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 84908178958     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.07.021     Document Type: Article

References (49)

1. L. Passamano, A. Taglia, A. Palladino, E. Viggiano, P. D'Ambrosio, M. Scutifero, M. Rosaria Cecio, V. Torre, F. De Luca, E. Picillo, O. Paciello, G. Piluso, G. Nigro, and L. Politano Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients Acta Myol 31 2012 121 125
2. P. Kieny, S. Chollet, P. Delalande, M. Le Fort, A. Magot, Y. Pereon, and B. Perrouin Verbe Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011 Ann Phys Rehabil Med 56 2013 443 454
3. G.B. Banks, and J.S. Chamberlain The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies Curr Top Dev Biol 84 2008 431 453
4. J.N. Kornegay, J.R. Bogan, D.J. Bogan, M.K. Childers, J. Li, P. Nghiem, D.A. Detwiler, C.A. Larsen, R.W. Grange, R.K. Bhavaraju-Sanka, S. Tou, B.P. Keene, J.F. Howard Jr., J. Wang, Z. Fan, S.J. Schatzberg, M.A. Styner, K.M. Flanigan, X. Xiao, and E.P. Hoffman Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies Mamm Genome 23 2012 85 108
5. A.E. Emery The muscular dystrophies Lancet 359 2002 687 695
6. M.C. Gasper, and J.M. Gilchrist Creatine kinase: a review of its use in the diagnosis of muscle disease Med Health R I 88 2005 398 400-404
7. K. Rouger, T. Larcher, L. Dubreil, J.Y. Deschamps, C. Le Guiner, G. Jouvion, B. Delorme, B. Lieubeau, M. Carlus, B. Fornasari, M. Theret, P. Orlando, M. Ledevin, C. Zuber, I. Leroux, S. Deleau, L. Guigand, I. Testault, E. Le Rumeur, M. Fiszman, and Y. Chérel Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs Am J Pathol 179 2011 2501 2518
8. I. Barthélémy, A. Uriarte, C. Drougard, Y. Unterfinger, J.L. Thibaud, and S. Blot Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy PLoS One 7 2012 e48478
9. M.J. Wood To skip or not to skip: that is the question for duchenne muscular dystrophy Mol Ther 21 2013 2131 2132
10. E.P. Hoffman, and E.M. McNally Exon-skipping therapy: a roadblock, detour, or bump in the road? Sci Transl Med 6 2014 230fs14
11. S.D. Wilton, S. Fletcher, and K.M. Flanigan Dystrophin as a therapeutic biomarker: are we ignoring data from the past? Neuromuscul Disord 24 2014 463 466
12. E.P. Hoffman, and E.M. Connor Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies Discov Med 16 2013 233 239
13. W.E. Kelley, J.L. Januzzi, and R.H. Christenson Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure Clin Chem 55 2009 2098 2112
14. T. Matsumura, T. Saito, H. Fujimura, and S. Shinno Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients Brain Dev 29 2007 496 501
15. M. Castro-Gago, C. Gómez-Lado, and J. Eirís-Puñal Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients (letter to the editor) BrainDev 31 2009 184
16. Y. Ergul, B. Ekici, K. Nisli, B. Tatli, F. Binboga, G. Acar, M. Ozmen, and R.E. Omeroglu Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy J Paediatr Child Health 48 2012 610 616
17. S. Schade van Westrum, L. Dekker, R. de Haan, E. Endert, I. Ginjaar, M. de Visser, and A. van der Kooi Brain natriuretic peptide is not predictive of dilated cardiomyopathy in Becker and Duchenne muscular dystrophy patients and carriers BMC Neurol 13 2013 88
18. J.A. Weber, D.H. Baxter, S. Zhang, D.Y. Huang, K.H. Huang, M.J. Lee, D.J. Galas, and K. Wang The microRNA spectrum in 12 body fluids Clin Chem 56 2010 1733 1741
19. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, and M. Tewari Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
20. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang, and C.Y. Zhang Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
21. M.A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A.K. Sood, and G.A. Calin MicroRNAs in body fluids-the mix of hormones and biomarkers Nat Rev Clin Oncol 8 2011 467 477
22. N. Vignier, F. Amor, P. Fogel, A. Duvallet, J. Poupiot, S. Charrier, M. Arock, M. Montus, I. Nelson, I. Richard, L. Carrier, L. Servais, T. Voit, G. Bonne, and D. Israeli Distinctive serum miRNA profile in mouse models of striated muscular pathologies PLoS One 8 2013 e55281
23. D. Cacchiarelli, I. Legnini, J. Martone, V. Cazzella, A. D'Amico, E. Bertini, and I. Bozzoni miRNAs as serum biomarkers for Duchenne muscular dystrophy EMBO Mol Med 3 2011 258 265
24. H. Mizuno, A. Nakamura, Y. Aoki, N. Ito, S. Kishi, K. Yamamoto, M. Sekiguchi, S. Takeda, and K. Hashido Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy PLoS One 6 2011 e18388
25. T.C. Roberts, K.E. Blomberg, G. McClorey, S.E. Andaloussi, C. Godfrey, C. Betts, T. Coursindel, M.J. Gait, C.I. Smith, and M.J. Wood Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy Mol Ther Nucleic Acids 1 2012 e39
26. I.T. Zaharieva, M. Calissano, M. Scoto, M. Preston, S. Cirak, L. Feng, J. Collins, R. Kole, M. Guglieri, V. Straub, K. Bushby, A. Ferlini, J.E. Morgan, and F. Muntoni Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular dystrophy PLoS One 8 2013 e80263
27. S. Duguez, W. Duddy, H. Johnston, J. Laine, M.C. Le Bihan, K.J. Brown, A. Bigot, Y. Hathout, G. Butler-Browne, and T. Partridge Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion Cell Mol Life Sci 70 2013 2159 2174
28. M.C. Le Bihan, A. Bigot, S.S. Jensen, J.L. Dennis, A. Rogowska-Wrzesinska, J. Laine, V. Gache, D. Furling, O.N. Jensen, T. Voit, V. Mouly, G.R. Coulton, and G. Butler-Browne In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts J Proteomics 77 2012 344 356
29. E.E. Creemers, A.J. Tijsen, and Y.M. Pinto Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110 2012 483 495
30. M.F. Corsten, R. Dennert, S. Jochems, T. Kuznetsova, Y. Devaux, L. Hofstra, D.R. Wagner, J.A. Staessen, S. Heymans, and B. Schroen Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease Circ Cardiovasc Genet 3 2010 499 506
31. V. Oliveira-Carvalho, V.O. Carvalho, and E.A. Bocchi The emerging role of miR-208a in the heart DNA Cell Biol 32 2013 8 12
32. G.K. Wang, J.Q. Zhu, J.T. Zhang, Q. Li, Y. Li, J. He, Y.W. Qin, and Q. Jing Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans Eur Heart J 31 2010 659 666
33. V. Chetboul, N. Athanassiadis, C. Carlos, A. Nicolle, L. Zilberstein, J.L. Pouchelon, H.P. Lefebvre, and D. Concordet Assessment of repeatability, reproducibility, and effect of anesthesia on determination of radial and longitudinal left ventricular velocities via tissue Doppler imaging in dogs Am J Vet Res 65 2004 909 915
34. J.B. Si, O. Carzorla, S. Blot, N. Blanchard-Gulton, Y. Ait Mou, I. Barthélémy, L. Sambin, C.C. Sampedrano, V. Gouni, Y. Unterfinger, P. Aguilar, J.L. Thibaud, A. Bizé, J.L. Pouchelon, H. Dabiré, B. Ghaleh, A. Berdeaux, V. Chetboul, A. Lacampagne, and L. Hittinger Bradykinin restores left ventricular function, sarcomeric protein phosphorylation, and e/nNOS levels in dogs with Duchenne muscular dystrophy cardiomyopathy Cardiovasc Res 95 2012 86 96
35. F. Vigneault, D. Ter-Ovanesyan, S. Alon, S. Eminaga, D.C. Christodoulou, J.G. Seidman, E. Eisenberg, and G.M. Church High-throughput multiplex sequencing of miRNA Curr Protoc Hum Genet 2012 Chapter 11:Unit 11.12.1-10
36. M. Hackenberg, N. Rodríguez-Ezpeleta, and A.M. Aransay miRanalyzer: an update on the detection and analysis of microRNAs in high-throughput sequencing experiments Nucleic Acids Res 39 2011 W132 W138
37. T. Barrientos, D. Frank, K. Kuwahara, S. Bezprozvannaya, G.C. Pipes, R. Bassel-Duby, J.A. Richardson, H.A. Katus, E.N. Olson, and N. Frey Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin J Biol Chem 282 2007 8393 8403
38. C.A. Edwards, A.J. Mungall, L. Matthews, E. Ryder, D.J. Gray, A.J. Pask, G. Shaw, J.A. Graves, J. Rogers SAVOIR consortium I. Dunham, M.B. Renfree, and A.C. Ferguson-Smith The evolution of the DLK1-DIO3 imprinted domain in mammals PLoS Biol 6 2008 e135
39. K. Byrne, M.L. Colgrave, T. Vuocolo, R. Pearson, C.A. Bidwell, N.E. Cockett, D.J. Lynn, J.N. Fleming-Waddell, and R.L. Tellam The imprinted retrotransposon-like gene PEG11 (RTL1) is expressed as a full-length protein in skeletal muscle from Callipyge sheep PLoS One 5 2010 e8638
40. J.N. Fleming-Waddell, G.R. Olbricht, T.M. Taxis, J.D. White, T. Vuocolo, B.A. Craig, R.L. Tellam, M.K. Neary, N.E. Cockett, and C.A. Bidwell Effect of DLK1 and RTL1 but not MEG3 or MEG8 on muscle gene expression in Callipyge lambs PLoS One 4 2009 e7399
41. C.M. Snyder, A.L. Rice, N.L. Estrella, A. Held, S.C. Kandarian, and F.J. Naya MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration Development 140 2013 31 42
42. C. Li, Z. Fang, T. Jiang, Q. Zhang, C. Liu, C. Zhang, and Y. Xiang Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris BMC Med Genomics 6 2013 16
43. X. Hou, Z. Tang, H. Liu, N. Wang, H. Ju, and K. Li Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletal muscles in pigs PLoS One 7 2012 e52123
44. L. Benetatos, E. Hatzimichael, E. Londin, G. Vartholomatos, P. Loher, I. Rigoutsos, and E. Briasoulis The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis Cell Mol Life Sci 70 2013 795 814
45. H.A. Heemskerk, C.L. de Winter, S.J. de Kimpe, P. van Kuik-Romeijn, N. Heuvelmans, G.J. Platenburg, G.J. van Ommen, J.C. van Deutekom, and A. Aartsma-Rus In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping J Gene Med 11 2009 257 266
46. F. Muntoni, and M.J. Wood Targeting RNA to treat neuromuscular disease Nat Rev Drug Discov 10 2011 621 637
47. E. van Rooij, D. Quiat, B.A. Johnson, L.B. Sutherland, X. Qi, J.A. Richardson, R.J. Kelm Jr., and E.N. Olson A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance Dev Cell 17 2009 662 673
48. P.K. Davidsen, I.J. Gallagher, J.W. Hartman, M.A. Tarnopolsky, F. Dela, J.W. Helge, J.A. Timmons, and S.M. Phillips High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression J Appl Physiol (1985) 110 2011 309 317
49. S. Greco, A. Perfetti, P. Fasanaro, R. Cardani, M.C. Capogrossi, G. Meola, and F. Martelli Deregulated microRNAs in myotonic dystrophy type 2 PLoS One 7 2012 e39732